Skip to main content
Genomictree Inc. logo

Genomictree Inc. — Investor Relations & Filings

Ticker · 228760 ISIN · KR7228760005 KO Professional, scientific and technical activities
Open in API
Filings indexed 237 across all filing types
Latest filing 2020-03-24 Declaration of Voting R…
Country KR South Korea
Listing KO 228760

About Genomictree Inc.

https://genomictree.com/eng/

Genomictree Inc. is a molecular diagnostics company that develops and commercializes products for the early detection and diagnosis of cancer. The company specializes in epigenomics, utilizing its proprietary genomic-scale discovery tools to identify DNA methylation biomarkers. Its flagship product line, EarlyTect®, offers non-invasive tests for the early screening of colorectal, lung, and bladder cancers. Additionally, Genomictree provides AccuraTect™, a companion diagnostic test for cancer. The company's mission is to improve patient quality of life and reduce medical costs through accessible and accurate early-stage cancer detection.

Recent filings

Filing Released Lang Actions
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official report of the results from a General Meeting of Shareholders (정기주주총회결과). It details the approval of financial statements, election of directors and auditors, and other resolutions passed during the meeting held on 2020-03-24. This falls under the category of Declaration of Voting Results & Voting Rights Announcements.
2020-03-24 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 95% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options). It is submitted to the Financial Services Commission/Korea Exchange and details the issuance of stock options to employees, including exercise price, vesting period, and valuation methodology. This type of disclosure regarding the issuance of new equity-based instruments (stock options) falls under the category of share issues or capital changes.
2020-03-24 Korean
[기재정정]임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a regulatory filing titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard disclosure document in South Korea (DART system) where insiders or major shareholders report their shareholdings or changes therein. This falls under the category of 'Director's Dealing' (DIRS) as it details the ownership status and changes in shareholdings by a major shareholder (KB Solidus Global Healthcare Fund) in the company (Genomictree).
2020-03-19 Korean
감사보고서제출
Audit Report / Information Classification · 97% confidence The document is a formal regulatory filing titled '감사보고서 제출' (Submission of Audit Report) submitted to the Korea Exchange (KRX). It contains key financial data, audit opinions, and financial statements for the fiscal year. While it provides financial summaries, it is a standard regulatory disclosure of the audit report rather than the full 10-K annual report document itself. In the context of Korean regulatory filings (DART/KIND), this is classified as an Audit Report/Information filing. FY 2019
2020-03-16 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서), which is a standard regulatory filing in South Korea (often referred to as a 5% rule filing). It details changes in share ownership by a major shareholder (Solidus Investment) in a company (Genomictree). This type of filing is specifically designed to notify the market and regulators of significant changes in shareholding thresholds. Based on the provided categories, this fits best under 'Major Shareholding Notification'.
2020-03-13 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the shareholding status, changes in ownership (acquisitions/disposals), and the purpose of holding (simple investment) by KB Investment and its related funds in the company 'Genomictree'. This falls under the 'Major Shareholding Notification' category.
2020-03-13 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.